Latest News - LabCorp
Top Corporates Hub
LabCorp
Labcorp Declares Quarterly Dividend
09.04.2026 10:50
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, announced today that its Board of Directors has declared a cash dividend of $0.72 per share of common stock. The dividend will be payable on June 11, 2026, to stockholders of record as of the close of business on May 29, 2026.
Labcorp Expands New York Reach And Precision Oncology Ambitions For Investors
26.03.2026 01:04
Labcorp Holdings (NYSE:LH) is expanding its New York footprint through the acquisition of assets and operations from Crouse Health and Lab Alliance. The company is also extending its collaboration with Illumina to advance precision oncology using next generation sequencing based cancer biomarker testing. The partnership aims to develop distributed in vitro diagnostic kits that support broader access to advanced oncology testing for patients and providers. For you as an investor, these moves...
Labcorp Expands New York Reach And Precision Oncology Ambitions For Investors
26.03.2026 01:04
Labcorp Holdings (NYSE:LH) is expanding its New York footprint through the acquisition of assets and operations from Crouse Health and Lab Alliance. The company is also extending its collaboration with Illumina to advance precision oncology using next generation sequencing based cancer biomarker testing. The partnership aims to develop distributed in vitro diagnostic kits that support broader access to advanced oncology testing for patients and providers. For you as an investor, these moves...
ILMN Stock Gains Following Expanded Collaboration With Labcorp
19.03.2026 17:17
Illumina gains after expanding Labcorp collaboration to boost NGS oncology adoption, broaden testing access, and drive growth in precision cancer care.
Why Is Labcorp (LH) Down 4.6% Since Last Earnings Report?
19.03.2026 15:30
Labcorp (LH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Q4 Earnings Outperformers: Labcorp (NYSE:LH) And The Rest Of The Testing & Diagnostics Services Stocks
09.03.2026 17:05
The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how testing & diagnostics services stocks fared in Q4, starting with Labcorp (NYSE:LH).
Is This the Right Time to Hold Labcorp Stock in Your Portfolio?
04.03.2026 13:14
LH eyes growth via specialty test expansion, acquisitions and LaunchPad savings, but currency headwinds and macro pressures cloud the outlook.
Is It Time To Reconsider Labcorp (LH) After Strong Healthcare Sector Coverage And DCF Upside?
02.03.2026 00:22
If you are wondering whether Labcorp Holdings is priced attractively right now, starting with a clear look at its valuation can help you decide how it fits into your portfolio. The stock recently closed at US$289.12, with reported returns of 2.3% over 7 days, 6.5% over 30 days, 14.9% year to date, 16.4% over 1 year, 45.9% over 3 years, and 48.5% over 5 years. Recent news coverage has focused on Labcorp Holdings' position in the healthcare sector and how its testing and diagnostics...
The 5 Most Interesting Analyst Questions From Labcorp’s Q4 Earnings Call
24.02.2026 05:33
Labcorp’s Q4 results came in below Wall Street’s revenue expectations, leading to a negative market reaction, while management attributed performance to strength in specialty testing and expanded partnerships with hospitals and regional labs. CEO Adam Schechter highlighted the company’s double-digit growth in esoteric testing and the successful integration of recent acquisitions, including Invitae and assets from various health systems. Schechter also acknowledged that lower organic volume growt
Labcorp Alzheimer’s Blood Test And Neurology Hire Spark Valuation Debate
19.02.2026 05:12
Labcorp Holdings (NYSE:LH) launched the first FDA cleared blood test to aid in the initial assessment of Alzheimer’s disease, the Elecsys pTau-181 test, with nationwide availability. The company also appointed Dr. John H. Sampson, a leading neurologist and researcher, to its Board of Directors. Labcorp, a large player in diagnostics and central laboratory services, is moving deeper into neurology focused testing with this Alzheimer’s blood test. The test offers a less invasive option...
Baird Maintains Outperform on Labcorp Hldgs, Raises Price Target to $326
18.02.2026 09:05
Baird analyst Eric Coldwell maintains Labcorp Hldgs (NYSE:LH) with a Outperform and raises the price target from $313 to $326.
LH Q4 Deep Dive: Specialty Testing and Hospital Partnerships Offset Volume Challenges
18.02.2026 05:32
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) missed Wall Street’s revenue expectations in Q4 CY2025, but sales rose 5.6% year on year to $3.52 billion. On the other hand, the company’s outlook for the full year was close to analysts’ estimates with revenue guided to $14.7 billion at the midpoint. Its non-GAAP profit of $4.07 per share was 3.2% above analysts’ consensus estimates.
Labcorp Holdings Inc. Q4 2025 Earnings Call Summary
18.02.2026 01:06
Moby summary of Labcorp Holdings Inc.'s Q4 2025 earnings call
Labcorp Announces 2025 Fourth Quarter and Full Year Results
17.02.2026 11:50
Labcorp Holdings Inc. (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced results for the fourth quarter and full year ended December 31, 2025, and provided 2026 guidance.
Labcorp (LH) To Report Earnings Tomorrow: Here Is What To Expect
16.02.2026 03:07
Healthcare diagnostics company Labcorp Holdings (NYSE:LH) will be announcing earnings results this Tuesday before market hours. Here’s what investors should know.
Labcorp's Q4 Earnings Preview: What's in Store for the Stock?
10.02.2026 13:57
LH heads into its Q4 earnings report with rising revenue and EPS expectations, driven by Diagnostics momentum, acquisitions and expanding test demand.
Assessing Labcorp Holdings (LH) Valuation After Guidance Cut And Restructuring Response
05.02.2026 01:09
Event driven focus on Labcorp Holdings (LH) Recent fund commentary flagged Labcorp Holdings (LH) as a performance detractor after reduced guidance tied to delayed acquisitions, a softer development pipeline, and a related business restructuring drew a measured reaction from investors. See our latest analysis for Labcorp Holdings. Those concerns around delayed acquisitions, a softer development pipeline, and restructuring came against a backdrop where Labcorp’s share price has a year to date...
MASHNET Announces Founding of MASLD Diagnostic Coalition
03.02.2026 14:38
MASHNET, a liver Network of Excellence powered by Petauri Kinect, announced today the formation of the MASLD Diagnostic Coalition, a multistakeholder collaboration united by a shared goal to advance access and awareness of non-invasive diagnostics for metabolic dysfunction-associated steatotic liver disease (MASLD).
Investor Concerns Impacted Labcorp (LH) in Q4
03.02.2026 13:10
Diamond Hill Capital, an investment management company, released its “Large Cap Fund” fourth-quarter 2025 investor letter. A copy of the letter can be downloaded here. Equity markets continued their upward momentum in Q4, with the Russell 1000 Value Index increasing 3.8%. The information technology (+11%) and communication services (+9%) sectors are leading the rally, driven by […]
2 Unprofitable Stocks with Promising Prospects and 1 We Turn Down
19.01.2026 04:34
Unprofitable companies can burn through cash quickly, leaving investors exposed if they fail to turn things around. Without a clear path to profitability, these businesses risk running out of capital or relying on dilutive fundraising.